Department of Ocular Oncology, Institut Curie, Paris, France.
Eye (Lond). 2011 Dec;25(12):1555-61. doi: 10.1038/eye.2011.198. Epub 2011 Sep 16.
To assess if systematic fundus screening according to an 'intensive' schedule alters ocular outcome and to propose fundus screening schedule guidelines for children related to a retinoblastoma patient.
For children with a positive family history of retinoblastoma, we perform fundus exams shortly after birth under general anaesthesia and then at regular intervals according to schedules based on the risk. Familial retinoblastoma cases seen at our institution from January 1995 to December 2004 were retrospectively classified as 'screened' or 'non-screened' (NS) and, among the 'screened' patients, as 'intensively screened' (IS) if screening matched our recommendations or 'non-intensively screened' (S). Groups were compared by Fisher exact test for categorical variables and Kruskal-Wallis test for continuous variables.
Among the 547 retinoblastoma patients managed at our institution during this period, 59 were familial cases. In all, 20 were in the NS group, 23 in the S group, and 16 in the IS group. The number of children enucleated was, respectively, 13, 2, and 0 (P<10(-4)); external beam radiation (EBRT) was required for, respectively, 6, 0, and 2 children (P<0.009). Chemotherapy burden and visual acuity were not significantly different between groups.
An 'intensive' fundus screening schedule decreased the need for enucleation and EBRT. Therefore, despite the heavy burden of the screening schedule, we recommend physicians and health-care professionals to better inform and refer children with a family history of retinoblastoma for genetic counselling and proper fundus screening in specialized centres.
评估根据“强化”方案进行系统性眼底筛查是否会改变眼部结局,并为与视网膜母细胞瘤患者相关的儿童提出眼底筛查方案指南。
对于有阳性家族史的儿童,我们在全身麻醉下出生后不久进行眼底检查,然后根据风险制定的时间表定期进行检查。本机构于 1995 年 1 月至 2004 年 12 月期间回顾性地将家族性视网膜母细胞瘤病例分为“筛查”或“未筛查”(NS),在“筛查”患者中,如果筛查符合我们的建议,则分为“强化筛查”(IS)或“非强化筛查”(S)。通过 Fisher 确切检验比较分类变量,通过 Kruskal-Wallis 检验比较连续变量。
在本机构管理的 547 例视网膜母细胞瘤患者中,有 59 例为家族性病例。在所有病例中,20 例为 NS 组,23 例为 S 组,16 例为 IS 组。分别有 13、2 和 0 例患儿需要行眼球摘除术(P<10(-4));分别有 6、0 和 2 例患儿需要行外照射放疗(EBRT)(P<0.009)。各组间化疗负担和视力无显著差异。
“强化”眼底筛查方案减少了眼球摘除术和 EBRT 的需求。因此,尽管筛查方案负担沉重,但我们建议医生和医疗保健专业人员更好地告知和转介有视网膜母细胞瘤家族史的儿童进行遗传咨询,并在专门中心进行适当的眼底筛查。